Judging by the fact that Voyager Therapeutics Inc (NASDAQ:VYGR) has faced falling interest from the entirety of the hedge funds we track, logic holds that there were a few fund managers that elected to cut their full holdings heading into Q4. Intriguingly, Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital cut the biggest investment of all the investors studied by Insider Monkey, valued at an estimated $0 million in stock. Joseph Edelman’s fund, Perceptive Advisors, also said goodbye to its stock, about $0 million worth.
Let’s now review hedge fund activity in other stocks similar to Voyager Therapeutics Inc (NASDAQ:VYGR). We will take a look at BioSpecifics Technologies Corp. (NASDAQ:BSTC), Compugen Ltd. (USA) (NASDAQ:CGEN), American Public Education, Inc. (NASDAQ:APEI), and Trinity Biotech plc (ADR) (NASDAQ:TRIB). This group of stocks’ market caps are closest to VYGR’s market cap.
|Ticker||No of HFs with positions||Total Value of HF Positions (x1000)||Change in HF Position|
As you can see these stocks had an average of 10 hedge funds with bullish positions and the average amount invested in these stocks was $38 million. That figure was $44 million in VYGR’s case. American Public Education, Inc. (NASDAQ:APEI) is the most popular stock in this table. On the other hand Compugen Ltd. (USA) (NASDAQ:CGEN) is the least popular one with only 5 bullish hedge fund positions. Voyager Therapeutics Inc (NASDAQ:VYGR) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. In this regard APEI might be a better candidate to consider taking a long position in.